Both a prospective survey and a retrospective study revealed that a reduction in the peripheral CD4+ T cells at the onset of AP is a simple, early, and an accurate parameter for predicting the clinical outcomes of AP or progression to persistent organ failure, with 61.54% sensitivity and 90% specificity (22, 23). The gene discussed is CD4; the disease is alkaline phosphatase measurement.